GALANTAMINE SR CH galantamine (as hydrobromide) 16mg modified release capsules blister pack

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

galantamine hydrobromide, Quantity: 20.504 mg (Equivalent: galantamine, Qty 16 mg)

Pieejams no:

Southern Cross Pharma Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

Galantamine hydrobromide

Zāļu forma:

Capsule, modified release

Kompozīcija:

Excipient Ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; Gelatin; magnesium stearate; microcrystalline cellulose

Ievadīšanas:

Oral

Vienības iepakojumā:

28

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type

Produktu pārskats:

Visual Identification: opaque flesh-flesh size 2 hard gelatin capsule containing two round biconvex tablets; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Licence status A

Autorizācija datums:

2015-07-03